GTL: an efficient solution to reduce raw material and production costs for API manufacturers
How GRIT’s GTL contributes to process optimization and cost reduction in pharmaceutical synthesis
The continuous increase in raw material prices and the growing pressure on operational costs have made efficiency a critical factor for manufacturers of active pharmaceutical ingredients (APIs). In this context, GTL (Gas-to-Liquid) solutions from GRIT—gases dissolved in organic solvents at precise concentrations—have become a valuable alternative that allows companies to reduce procurement and production costs without compromising the final quality of the API.
What GTL means at GRIT and why it is so relevant for the pharmaceutical industry
GRIT’s GTL does not refer to synthetic fuels but to specific gas solutions (HCl, NH₃, gaseous amines, etc.) dissolved in organic solvents such as methanol, ethanol, IPA, THF, or CPME.
This technology makes it possible to supply reactive gases ready to use, in liquid form, avoiding the need to directly handle pressurized gases.
You can read more here:
How GTL reduces raw material costs in API synthesis
The volatility in the prices of traditional solvents and industrial gases has a direct impact on the production cost of an API. GTL solutions help reduce raw material costs in several ways:
- Reduction in gas waste thanks to precise, fully usable concentrations.
- Optimized solvent consumption, avoiding over-adjustments or repeated corrections.
- Elimination of equipment and consumables associated with pressurized gases, such as regulators, valves, or vaporizers.
- Logistical savings, since transporting and storing liquids is simpler and less expensive than handling gases under pressure.
More technical information:
Production cost savings thanks to GTL’s operational efficiency
Beyond the direct impact on raw material costs, GTL also provides operational savings derived from improved efficiency in industrial processes:
- Reduced downtime, as reactants are supplied already prepared in solution form.
- Greater batch-to-batch reproducibility, essential for GMP compliance and for reducing reprocessing.
- Improved safety, which lowers costs related to training, audits, and maintenance of gas-handling equipment.
- Easy scalability, enabling the same formulation to be used in R&D, pilot plant, and full-scale production.
GRIT explains these benefits in detail in:
GTL as a strategic ally for API manufacturers
The combination of safety, efficiency, and cost reduction makes GTL a strategic tool for API manufacturers seeking to stabilize their supply chain and increase competitiveness. GRIT provides tailored formulations, technical support during implementation, and continuous supply, ensuring a smooth transition to a more efficient production model.
■ Communication Team
